HBRM Stock UPDATES Herborium Group Inc. (HBRM) 0.0200 09/18/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Herborium Group Inc. (HBRM) 0.0200 $HBRM

Herborium Group starts the commercialization of its sexual health formulas; ready to take advantage of $1.5 billion market.
GlobeNewswire - Thu Sep 11, 9:17AM CDT
Herborium Group, Inc., (HBRM) www.herborium.com, a Botanical Therapeutics(R) Company has announced today that it has signed an agreement with a Florida company to commercialize its proprietary, all botanical based sexual Botanical Therapeutics(R): The Lasting Pleasure(R) for Women and Lasting Power(R) for Men. The products are going to be on the market in 4 quarter of 2014.

Herborium Group enters $300 billion plus mobile sales market;
GlobeNewswire - Thu Aug 21, 8:30AM CDT
Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicinal products (Botanical Therapeutics(R)) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress, has successfully deployed a responsive design e-commerce infrastructure and joined $300 billion plus mobile market.

Herborium Group's 2014 First Seven Months Sales Surpasses 2013 Annual Sales.
GlobeNewswire - Thu Jul 24, 7:41AM CDT
Fort Lee, N.J. July 24, 2014 Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicinal products (Botanical Therapeutics(R)) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress, reports that its sales for the first seven months of 2014 has surpassed the sales realized in the entire year of 2013. This reaffirms the present run rate for AcnEase(R) sales for 2014 to exceed $1 million dollars.

Herborium Group's Second Quarter Sales Grows over 132%
GlobeNewswire - Thu Jul 17, 7:30AM CDT
Fort Lee, N.J. July 16, 2014 Herborium(R) Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicinal products (Botanical Therapeutics(R)) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress, reports that its sales for the Second Quarter of 2014 grew by 132 % in comparison to the same period of 2013. This puts the present run rate for AcnEase(R) sales for 2014 to exceed $1 million dollars. .

Herborium Group First Quarter Sales Grows 45%; Debt reduced by $1Million
Marketwire - Thu Mar 27, 7:17AM CDT
Herborium(R) Group, Inc. (OTC Pink: HBRM) (PINKSHEETS: HBRM), www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of unique all botanical medicinal products (Botanical Therapeutics(R)) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress reports that its sales for the First Quarter of 2014 grew by 45.2 %in comparison to the same period of 2013 and puts the present running rate for AcnEase sales only for 2014 to over $750,000. Herborium expects that this strong growth that is continuing now for the fifth consecutive quarter will prevail though 2014 putting the Company in a black for the year.

Vibra Bank Announces A New Growth Phase and Welcomes Frank Mercardante as its New CEO
PR Newswire - Fri Feb 14, 8:00AM CST
Vibra Bank, one of the only remaining locally-owned banks, announced that its Board of Directors has appointed Frank Mercardante as President and Chief Executive Officer effective February 17, 2014. Mr. Mercardante replaces Scott Parker, Vibra Bank's former CEO, who successfully led the bank from its inception until his recent resignation.

Herborium Group Increases Its January Sales by 90% in Comparison to 2013
Marketwire - Wed Feb 12, 7:45AM CST
Herborium(R) Group, Inc. (OTC Pink: HBRM) (OTC Pink: HBRMD) (http://www.herborium.com/), a Botanical Therapeutics(R) Company and the provider of AcnEase(R), the one of a kind Botanical Therapeutic(R) for acne, increased its January sales by 90% in comparison to the same month of 2013.

The Search is on in New Jersey for EY's 2014 Most Innovative Entrepreneurs
PR Newswire - Tue Feb 04, 8:00AM CST
EY is calling for nominations for the 28th Annual EY Entrepreneur Of The Year Awards, recognized as one of the most prestigious business award programs in the country. The program has a firm deadline of March 14, 2014 for nominations, with the New Jersey awards ceremony scheduled for June 26th, 2014 at the Hyatt Regency New Brunswick.

Major Pan-European Insurer Selects Sapiens P&C for Implementation in 5 Countries
PR Newswire - Wed Jan 29, 6:12AM CST
Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, announced today that a leading global multi-line insurance provider has selected Sapiens IDIT Software Suite (Sapiens IDIT) to support its new liability and indemnity lines of business. The initial implementation of the new system will be deployed in UK, France, Germany, Italy and Spain.

Herborium Group Decreases the Number of Authorized Shares, Approves the Reverse Stock Split and Decreases Company Debt by One Million Dollars
Marketwire - Mon Jan 27, 12:00PM CST
Herborium(R) Group, Inc. (OTC Pink: HBRMD) (OTC Pink: HBRM), www.herborium.com, a Botanical Therapeutics(R) Company announced today that on January 14, 2014, the Board of Directors and shareholders owning the majority of the voting securities of Herborium Group, Inc. approved a decrease in the number of the Company's authorized common shares, rolling the number back to 950,000,000 shares. The Board and majority shareholders have also authorized a 1,000 to 1 reverse common stock split (the "Reverse Split" . In addition, a reduction of the Company's debt by $1 million dollars was achieved by Management's conversion of a substantial portion of their accrued salaries, disclosed as liabilities on the balance sheet of the Company, at a conversion rate of $0.0004 for one Common Share, representing more than 60% premium over the current public market price (the "Conversion Transaction" . This Conversion Transaction expresses a high level of trust in the Company's future by Management.

LeSportsac Announces 40 Years of Fashion & Function Through a Series of Unexpected Partnerships and Surprises in 2014
PR Newswire - Fri Jan 24, 8:01AM CST
Today the iconic American lifestyle bag retailer LeSportsac, announces the celebration of their 40th Anniversary. Established in 1974 in New York City, LeSportsac was founded on the principles of being lightweight, functional and fashionable.

Herborium Group Exceeds Sales Expectations for the Third Quarter
ACCESSWIRE - Thu Sep 12, 7:50AM CDT
Year to date sales growth 30%

Herborium Group Partners with Hut Group, the UK's Leading Online Retail Platform, to Take Advantage of $3 Billion Market for Acne Therapeutics
GlobeNewswire - Thu Jun 13, 7:50AM CDT
via PRWEB - Herborium Group, Inc., (OTC Pink: HBRM) http://www.herborium.com, a Botanical Therapeutics(R) Company has announced today that it has partnered with the leading online retail platform in the UK, The Hut Group, to market AcnEase(R), an all botanical therapeutic for acne, to consumers in the UK, EU and Australia. Since 2010 when The Hut Group raised £14 million to fund its growth, its sales rose 600%. AcnEase(R) sales in the first quarter of 2013 grew 52% in comparison to the first quarter of 2012.

Herborium Group Announces Partnership With Former WWE Pro-Wrestler Danny Gimondo To Help Combat Male Acne
PRWeb - Wed Jun 12, 9:13AM CDT
Herborium(R) Group, Inc. (OTC Pink: HBRM), http://www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of AcnEase(R), one of a kind Botanical Therapeutic(R) for acne launches a large scale male acne campaign with former WWE pro-wrestler Danny Gimondo as its spokesperson.

Herborium Group Engages Former WWE Pro-Wrestler Danny Gimondo as a Spokesperson for Male Acne
PRWeb - Tue Jun 11, 8:26AM CDT
Herborium(R) Group, Inc. (OTC Pink: HBRM), http://www.Herborium.com, a Botanical Therapeutics(R) Company and the provider of AcnEase(R), the one of a kind Botanical Therapeutic(R) for acne launches a massive male acne campaign with former WWE pro-wrestler Danny Gimondo as its spokesperson.

Herborium Group Launches 4-Week Acne Boot Camp to Combat Chronic Acne with AcnEase(R)
PRWeb - Thu May 30, 12:35PM CDT
Herborium(R) Group, Inc. (OTC Pink: HBRM), http://www.herborium.com, a Botanical Therapeutics(R) Company and the provider of AcnEase(R), a one of a kind natural acne medicine, launches a massive multi-factor anti-acne campaign to support National Acne Awareness Month. 150 million women and men in the U.S., Canada and Europe suffer from acne. During the past 10 years, adult acne has been on the rise, and the average age of an acne sufferer has increased from the age of 20.5 to 26.5 years old.

Herborium Group Partners with Hut Group, the Leading Online UK Retail Platform to Take Advantage of $3 Billion Market for Acne Therapeutics
PRWeb - Tue Apr 16, 7:31AM CDT
Herborium Group, Inc., (OTC Pink: HBRM) http://www.herborium.com, a Botanical Therapeutics(R) Company has announced today that it has partnered with the leading online retail platform in the UK, The Hut Group, to market AcnEase(R), an all botanical therapeutic for acne, to consumers in the UK, EU and Australia. Since 2010 when The Hut Group raised £14 million to fund its growth, its sales rose 600%. AcnEase(R) sales in the First Quarter of 2013 grew 52% in comparison to the First Quarter of 2012.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Heparin Market's Growth to Reach USD 9.68 Billion in Coming Years

Updated Category News Views 138

Heparin Market Size and Growth Insights The heparin market is witnessing promising growth, projected to attain USD 9.68 billion by the end of 2032, from its current market size of USD 7.35 billion in 2023. This growth is largely attributable to the escalating prevalence of cardiovascular diseases and conditions like venous thromboembolism (VTE). The compound annual growth...

Continue Reading
Discover Apple Intelligence: Creative Tools and Enhanced Features

Updated Category News Views 163

Unlock the Magic of Apple Intelligence Apple has taken a bold step forward with the unveiling of its latest update, showcasing the power of Apple Intelligence. With the rollout of iOS 18.2, iPadOS 18.2, and macOS Sequoia 15.2, users can dive into an array of new features designed to enhance their Apple experience. This exciting update introduces tools that not only...

Continue Reading
Diversified Energy Company Finalizes Maverick Acquisition Deal

Updated Category News Views 123

Diversified Energy Company Completes Significant Acquisition Diversified Energy Company PLC (DEC), an independent energy leader focused on natural gas and liquids, has made a notable stride in enhancing its market presence. The company recently finalized its acquisition of Maverick Natural Resources, an endeavor highlighted in previous announcements. Details of the...

Continue Reading
Glen Burnie Bancorp Shows Growth in Latest Earnings Report

Updated Category News Views 214

Glen Burnie Bancorp Reports Third Quarter Growth Glen Burnie Bancorp, known for its strong community banking focus, reported noteworthy financial results for its latest third quarter. This period has showcased various enhancements in performance metrics, positioning the organization favorably within the competitive landscape of banking. Financial Highlights Net Income and...

Continue Reading
Navient Announces Exciting Q4 2025 Dividend for Shareholders

Updated Category News Views 144

Navient's Fourth Quarter Dividend Announcement Navient (NASDAQ: NAVI), a leading provider in student loan services, has made headlines with the announcement of its fourth quarter dividend for 2025. The company's board of directors has approved a dividend of $0.16 per share on its common stock. Details of the Dividend This dividend declaration is a testament to Navient's...

Continue Reading